Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

SHE:301617 Revenue

Shandong Boyuan Pharmaceutical & Chemical had revenue of 391.13M CNY in the quarter ending March 31, 2026, with 22.14% growth. This brings the company's revenue in the last twelve months to 1.54B, up 14.57% year-over-year. In the year 2025, Shandong Boyuan Pharmaceutical & Chemical had annual revenue of 1.46B with 10.30% growth.

• Revenue (ttm): 1.54B
• Revenue Growth: +14.57%
• P/S Ratio: 5.87
• Revenue / Employee: 2.05M
• Employees: 748
• Market Cap: 9.02B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.46B	136.80M	10.30%
Dec 31, 2024	1.33B	302.73M	29.53%
Dec 31, 2023	1.03B	226.68M	28.39%
Dec 31, 2022	798.47M	274.10M	52.27%
Dec 31, 2021	524.37M	144.93M	38.20%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error